Package Label-principal Display Panel (10 mg (90 Tablets Bottle))
Loratadine Tablet
Product Images NDC 58602-847
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Loratadine (NDC 58602-847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label-principal Display Panel (10 mg Container Carton (90 Tablets))
This is a drug facts sheet which provides guidelines for taking a medicine. Individuals who are 6 years-old and above can take the medicine once a day but not more than one tablet within 24 hours. Those with liver or kidney disease should consult their doctor before using it. It provides relief from hay fever-related symptoms such as runny nose, itching of the throat or nose, and watery eyes. Pregnant or breastfeeding individuals should ask for professional advice before using it. The medicine should be kept away from children, and medical help should be sought in case of an overdose. The manufacturer recommends storing it at 20° to 25°C and protecting it from excessive moisture. It is not manufactured or distributed by Bayer Healthcare LLC, the distributor of Clartin®.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
